191 related articles for article (PubMed ID: 25015961)
1. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
[TBL] [Abstract][Full Text] [Related]
2. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes.
MacDonnell SM; Weisser-Thomas J; Kubo H; Hanscome M; Liu Q; Jaleel N; Berretta R; Chen X; Brown JH; Sabri AK; Molkentin JD; Houser SR
Circ Res; 2009 Aug; 105(4):316-25. PubMed ID: 19608982
[TBL] [Abstract][Full Text] [Related]
3. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
4. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
[TBL] [Abstract][Full Text] [Related]
5. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.
Donaldson C; Eder S; Baker C; Aronovitz MJ; Weiss AD; Hall-Porter M; Wang F; Ackerman A; Karas RH; Molkentin JD; Patten RD
Circ Res; 2009 Jan; 104(2):265-75, 11p following 275. PubMed ID: 19074476
[TBL] [Abstract][Full Text] [Related]
6. Effects of thapsigargin and phenylephrine on calcineurin and protein kinase C signaling functions in cardiac myocytes.
Prasad AM; Inesi G
Am J Physiol Cell Physiol; 2009 May; 296(5):C992-C1002. PubMed ID: 19244478
[TBL] [Abstract][Full Text] [Related]
7. Enhanced hypertrophy in ob/ob mice due to an impairment in expression of atrial natriuretic peptide.
Mascareno E; Beckles D; Dhar-Mascareno M; Siddiqui MA
Vascul Pharmacol; 2009; 51(2-3):198-204. PubMed ID: 19560554
[TBL] [Abstract][Full Text] [Related]
8. Prevention of hypertrophy by overexpression of Kv4.2 in cultured neonatal cardiomyocytes.
Zobel C; Kassiri Z; Nguyen TT; Meng Y; Backx PH
Circulation; 2002 Oct; 106(18):2385-91. PubMed ID: 12403671
[TBL] [Abstract][Full Text] [Related]
9. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
[TBL] [Abstract][Full Text] [Related]
10. Accelerated development of pressure overload-induced cardiac hypertrophy and dysfunction in an RyR2-R176Q knockin mouse model.
van Oort RJ; Respress JL; Li N; Reynolds C; De Almeida AC; Skapura DG; De Windt LJ; Wehrens XH
Hypertension; 2010 Apr; 55(4):932-8. PubMed ID: 20157052
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signaling pathway in H9c2 myocardiac cells.
Liu CJ; Cheng YC; Lee KW; Hsu HH; Chu CH; Tsai FJ; Tsai CH; Chu CY; Liu JY; Kuo WW; Huang CY
Mol Cell Biochem; 2008 Jun; 313(1-2):167-78. PubMed ID: 18398669
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms underlying rate-dependent remodeling of transient outward potassium current in canine ventricular myocytes.
Xiao L; Coutu P; Villeneuve LR; Tadevosyan A; Maguy A; Le Bouter S; Allen BG; Nattel S
Circ Res; 2008 Sep; 103(7):733-42. PubMed ID: 18723449
[TBL] [Abstract][Full Text] [Related]
13. Scutellarin exerts its anti-hypertrophic effects via suppressing the Ca2+-mediated calcineurin and CaMKII signaling pathways.
Pan ZW; Zhang Y; Mei DH; Zhang R; Wang JH; Zhang XY; Xu CQ; Lu YJ; Yang BF
Naunyn Schmiedebergs Arch Pharmacol; 2010 Feb; 381(2):137-45. PubMed ID: 20052460
[TBL] [Abstract][Full Text] [Related]
14. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
[TBL] [Abstract][Full Text] [Related]
16. Normalization of the calcineurin pathway underlies the regression of hypertensive hypertrophy induced by Na+/H+ exchanger-1 (NHE-1) inhibition.
Ennis IL; Garciarena CD; Escudero EM; Pérez NG; Dulce RA; Camilión de Hurtado MC; Cingolani HE
Can J Physiol Pharmacol; 2007; 85(3-4):301-10. PubMed ID: 17612638
[TBL] [Abstract][Full Text] [Related]
17. Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes.
Tongers J; Fiedler B; König D; Kempf T; Klein G; Heineke J; Kraft T; Gambaryan S; Lohmann SM; Drexler H; Wollert KC
Cardiovasc Res; 2004 Aug; 63(3):545-52. PubMed ID: 15276480
[TBL] [Abstract][Full Text] [Related]
18. Plasma membrane Ca2+-ATPase isoform 4 antagonizes cardiac hypertrophy in association with calcineurin inhibition in rodents.
Wu X; Chang B; Blair NS; Sargent M; York AJ; Robbins J; Shull GE; Molkentin JD
J Clin Invest; 2009 Apr; 119(4):976-85. PubMed ID: 19287093
[TBL] [Abstract][Full Text] [Related]
19. Effects of combination of irbesartan and perindopril on calcineurin expression and sarcoplasmic reticulum Ca2+-ATPase activity in rat cardiac pressure-overload hypertrophy.
Jiang QJ; Xu G; Mao FF; Zhu YF
J Zhejiang Univ Sci B; 2006 Mar; 7(3):228-34. PubMed ID: 16502511
[TBL] [Abstract][Full Text] [Related]
20. Gestational diabetes triggers postpartum cardiac hypertrophy via activation of calcineurin/NFAT signaling.
Verma N; Srodulski S; Velmurugan S; Hoskins A; Pandey VK; Despa F; Despa S
Sci Rep; 2021 Oct; 11(1):20926. PubMed ID: 34686739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
